BS. Plus Mochida has a NASH patent and Amarin has a partnership with Mochida. Plus plus RIt trial has NASH data yet to be published that says while Amarin is intending to file for a NASH indication, how could thjey let GILD take it not even for a song? Ridiculous!
Gilead is not taking anything. Just like Amarin didn't take statins away from their manufacturers in the REDUCE-IT trial.